Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine …
A Asatryan, N Meyer, M Scherbakov… - Human Vaccines & …, 2021 - Taylor & Francis
… The objective of this study was to assess immunogenicity, reactogenicity and safety of a …
diphtheria and tetanus and >96.0% of participants were seropositive for anti-pertussis antibodies…
diphtheria and tetanus and >96.0% of participants were seropositive for anti-pertussis antibodies…
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases
P Van den Steen, B Cheuvart, Q Deraedt… - Human Vaccines & …, 2023 - Taylor & Francis
… immunogenicity in such patients. We performed a meta-analysis on 5 clinical trials in adults
receiving reduced-antigen tetanus-diphtheria-acellular … immunogenicity and reactogenicity …
receiving reduced-antigen tetanus-diphtheria-acellular … immunogenicity and reactogenicity …
[HTML][HTML] Immunogenicity and antibody persistence of diphteria-tetanus-acellular pertussis vaccination in adolescents and adults: A systematic review of the literature …
R Squeri, C Genovese - Journal of Preventive Medicine and …, 2020 - ncbi.nlm.nih.gov
… Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content
diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy …
diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy …
[HTML][HTML] Reactogenicity and safety of second trimester maternal tetanus, diphtheria and acellular pertussis vaccination in the Netherlands
MM Immink, JM Kemmeren, L Broeders, MN Bekker… - Vaccine, 2023 - Elsevier
… regarding acceptance, reactogenicity and immunogenicity of maternal … Reactogenicity
data were compared with data from a randomized controlled trial that studied immunogenicity …
data were compared with data from a randomized controlled trial that studied immunogenicity …
[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …
FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
… A cohort study examining reactogenicity of Tdap in pregnant women included only … reduced
antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic …
antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic …
Quantity and quality of antibodies after acellular versus whole-cell pertussis vaccines in infants born to mothers who received tetanus, diphtheria, and acellular …
N Wanlapakorn, K Maertens… - Clinical Infectious …, 2020 - academic.oup.com
… exclusion criteria, vaccine reactogenicity, and B. … of immunogenicity between different
manufacturers [31]. Quinvaxem may contain reduced amounts of FHA and PRN, resulting in lower …
manufacturers [31]. Quinvaxem may contain reduced amounts of FHA and PRN, resulting in lower …
Immunogenicity and safety of concomitant administration of the chinese inactivated poliovirus vaccine with the diphtheria-tetanus-acellular pertussis (DTaP) vaccine in …
X Sun, Y Xu, F Tang, Y Xiao, Z Wang, B Wang… - Frontiers in …, 2022 - frontiersin.org
… Safety and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated
poliovirus-haemophilus influenzae type b (DTPa-IPV/Hib) vaccine in healthy Vietnamese …
poliovirus-haemophilus influenzae type b (DTPa-IPV/Hib) vaccine in healthy Vietnamese …
[HTML][HTML] Immunogenicity and antibody persistence of diphteriatetanus-acellular pertussis vaccination in adolescents and adults: a systematic review of the literature …
R Squeri, C Genovese - J Prev Med Hyg, 2021 - ncbi.nlm.nih.gov
… Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content
diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy …
diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy …
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and …
NP Klein, R Abu-Elyazeed, B Cheuvart… - Human Vaccines & …, 2019 - Taylor & Francis
… Reactogenicity and safety profiles were similar for the 3 regimens, with a possible trend
for lower reactogenicity after hexavalent DTaP-HBV-IPV/Hib vaccination. The clinical …
for lower reactogenicity after hexavalent DTaP-HBV-IPV/Hib vaccination. The clinical …
Safety and immunogenicity of a respiratory syncytial virus prefusion F vaccine when coadministered with a tetanus, diphtheria, and acellular pertussis vaccine
JT Peterson, AM Zareba, D Fitz-Patrick… - The Journal of …, 2022 - academic.oup.com
… This study evaluated concomitant administration of RSV stabilized prefusion F subunit vaccine
(RSVpreF) and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine …
(RSVpreF) and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine …